Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Milene D, Miranda"'
Autor:
Pedro Henrique R. de A. Azevedo, Priscila G. Camargo, Larissa E. C. Constant, Stephany da S. Costa, Celimar Sinézia Silva, Alice S. Rosa, Daniel D. C. Souza, Amanda R. Tucci, Vivian N. S. Ferreira, Thamara Kelcya F. Oliveira, Nathalia R. R. Borba, Carlos R. Rodrigues, Magaly G. Albuquerque, Luiza R. S. Dias, Rafael Garrett, Milene D. Miranda, Diego Allonso, Camilo Henrique da S. Lima, Estela Maris F. Muri
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract COVID-19 is a multisystemic disease caused by the SARS-CoV-2 airborne virus, a member of the Coronaviridae family. It has a positive sense single-stranded RNA genome and encodes two non-structural proteins through viral cysteine-proteases pr
Externí odkaz:
https://doaj.org/article/e01b592981ca41dcbf917ad582e8025a
Autor:
Milene D. Miranda, Otávio Augusto Chaves, Alice S. Rosa, Alexandre R. Azevedo, Luiz Carlos da Silva Pinheiro, Vinicius C. Soares, Suelen S. G. Dias, Juliana L. Abrantes, Alice Maria R. Bernardino, Izabel C. P. Paixão, Thiago Moreno L. Souza, Carlos Frederico L. Fontes
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8135 (2022)
Herpes simplex virus type-1 (HSV-1) infection causes several disorders, and acyclovir is used as a reference compound. However, resistant strains are commonly observed. Herein, we investigate the effects of N-heterocyclic compounds (pyrazolopyridine
Externí odkaz:
https://doaj.org/article/d38df581fc1e4cb6a08a37147177a883
Autor:
Artur Capão, Maria L. Aguiar-Oliveira, Braulia C. Caetano, Thayssa K. Neves, Paola C. Resende, Walquiria A. F. Almeida, Milene D. Miranda, Olindo A. Martins-Filho, David Brown, Marilda M. Siqueira, Cristiana C. Garcia
Publikováno v:
Viruses, Vol 14, Iss 8, p 1692 (2022)
Annual vaccination against influenza is the best tool to prevent deaths and hospitalizations. Regular updates of trivalent inactivated influenza vaccines (TIV) are necessary due to high mutation rates in influenza viruses. TIV effectiveness is affect
Externí odkaz:
https://doaj.org/article/5ce4e99d11064ea5b8eb0c6f876b2782
Autor:
Suelen Silva Gomes Dias, Vinicius Cardoso Soares, André C Ferreira, Carolina Q Sacramento, Natalia Fintelman-Rodrigues, Jairo R Temerozo, Lívia Teixeira, Marcos Alexandre Nunes da Silva, Ester Barreto, Mayara Mattos, Caroline S de Freitas, Isaclaudia G Azevedo-Quintanilha, Pedro Paulo A Manso, Milene D Miranda, Marilda Mendonça Siqueira, Eugenio D Hottz, Camila R R Pão, Dumith C Bou-Habib, Debora F Barreto-Vieira, Fernando A Bozza, Thiago M L Souza, Patricia T Bozza
Publikováno v:
PLoS Pathogens, Vol 16, Iss 12, p e1009127 (2020)
Viruses are obligate intracellular parasites that make use of the host metabolic machineries to meet their biosynthetic needs. Thus, identifying the host pathways essential for the virus replication may lead to potential targets for therapeutic inter
Externí odkaz:
https://doaj.org/article/efc5a0370f864f88af78a38a55522ac3
Autor:
Juliana G. Melgaço, Tamiris Azamor, Andréa M. V. Silva, José Henrique R. Linhares, Tiago P. dos Santos, Ygara S. Mendes, Sheila M. B. de Lima, Camilla Bayma Fernandes, Jane da Silva, Alessandro F. de Souza, Luciana N. Tubarão, Danielle Brito e Cunha, Tamires B. S. Pereira, Catarina E. L. Menezes, Milene D. Miranda, Aline R. Matos, Braulia C. Caetano, Jéssica S. C. C. Martins, Thyago L. Calvo, Natalia F. Rodrigues, Carolina Q. Sacramento, Marilda M. Siqueira, Milton O. Moraes, Sotiris Missailidis, Patrícia C. C. Neves, Ana Paula D. Ano Bom
Publikováno v:
Cells, Vol 10, Iss 9, p 2206 (2021)
The cellular immune response plays an important role in COVID-19, caused by SARS-CoV-2. This feature makes use of in vitro models’ useful tools to evaluate vaccines and biopharmaceutical effects. Here, we developed a two-step model to evaluate the
Externí odkaz:
https://doaj.org/article/ef6211d1666f4e449c593d5565c89dee
Autor:
Guilherme S. Caleffi, Alice S. Rosa, Luana G. de Souza, João L. S. Avelar, Sarah M. R. Nascimento, Vitor M. de Almeida, Amanda R. Tucci, Vivian N. Ferreira, Alcides J. M. da Silva, Osvaldo A. Santos-Filho, Milene D. Miranda, Paulo R. R. Costa
Publikováno v:
Journal of Natural Products.
Autor:
Amanda R. Tucci, Fernanda das Neves Costa, Rosineide Costa Simas, Pedro Henrique Nascimento, Romain Sausset, Maria Eduarda S Monteiro, Simony C. Mendonça, Manuela Leal da Silva, Caio Cheohen, Tayssa Santos Gondim, Carla Monteiro Leal, Natalia Fintelman-Rodrigues, Milene D. Miranda, Maria Eduarda A Esteves, Marilda M. Siqueira, Gilda Guimarães Leitão, Suzana G. Leitão
Publikováno v:
Revista Brasileira de Farmacognosia. 31:658-666
The novel coronavirus SARS-CoV-2 has been affecting the world, causing severe pneumonia and acute respiratory syndrome, leading people to death. Therefore, the search for anti-SARS-CoV-2 compounds is pivotal for public health. Natural products may pr
Autor:
Tiago Pereira dos Santos, Milene D. Miranda, Thyago Leal Calvo, Tamiris Azamor, Jane da Silva, Juliana Gil Melgaço, Catarina E L Menezes, Tamires B S Pereira, Luciana N. Tubarão, Natalia Fintelman Rodrigues, Danielle Brito E Cunha, Patrícia Cristina da Costa Neves, Alessandro F. de Souza, Andréa Marques Vieira da Silva, Marilda M. Siqueira, Braulia Costa Caetano, Aline R. Matos, Milton Ozório Moraes, Sotiris Missailidis, Ygara S. Mendes, Carolina Q. Sacramento, Ana Paula Dinis Ano Bom, José Henrique Rezende Linhares, Jéssica S C C Martins, Camilla Bayma Fernandes, Sheila Maria Barbosa de Lima
Publikováno v:
Cells
Volume 10
Issue 9
Cells, Vol 10, Iss 2206, p 2206 (2021)
Volume 10
Issue 9
Cells, Vol 10, Iss 2206, p 2206 (2021)
The cellular immune response plays an important role in COVID-19, caused by SARS-CoV-2. This feature makes use of in vitro models’ useful tools to evaluate vaccines and biopharmaceutical effects. Here, we developed a two-step model to evaluate the
Autor:
Jairo R. Temerozo, Andrew Owen, Aline de Paula Dias Da Silva, Carolina Q. Sacramento, Thiago Moreno L. Souza, Suzana de Siqueira Santos, Rajith K. R. Rajoli, Marcos Alexandre Nunes da Silva, Milene D. Miranda, Natalia Fintelman-Rodrigues, Alberto Paccanaro, Mateo Torres, Mayara Mattos, Debora Ferreira Barreto-Vieira, Dumith Chequer Bou-Habib, André C. Ferreira, Suelen da Silva Gomes Dias, Filipe S. Pereira-Dutra, Carine dos Santos da Silva, Patrícia T. Bozza, Vinicius Cardoso Soares
Repositioning of clinical approved drugs could represent the fastest way to identify therapeutic options during public health emergencies, the majority of drugs explored for repurposing as antivirals for 2019 coronavirus disease (COVID-19) have faile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eed22684af6785e94edb82898b07fd87
https://doi.org/10.1101/2021.07.21.451321
https://doi.org/10.1101/2021.07.21.451321
Autor:
Aline R. Matos, Paola Cristina Resende, Cristiana C. Garcia, Debora Ferreira Barreto-Vieira, Wendell Girard-Dias, Fernando Couto Motta, Marcos Alexandre Nunes da Silva, Ortrud Monika Barth, Milene D. Miranda, Braulio S. Archanjo, Marilda M. Siqueira, Braulia Costa Caetano
Publikováno v:
Memórias do Instituto Oswaldo Cruz
Memórias do Instituto Oswaldo Cruz.
Memórias do Instituto Oswaldo Cruz, Volume: 116, Article number: e200443, Published: 08 FEB 2021
Memórias do Instituto Oswaldo Cruz.
Memórias do Instituto Oswaldo Cruz, Volume: 116, Article number: e200443, Published: 08 FEB 2021
BACKGROUND The coronaviruses (CoVs) called the attention of the world for causing outbreaks of severe acute respiratory syndrome (SARS-CoV), in Asia in 2002-03, and respiratory disease in the Middle East (MERS-CoV), in 2012. In December 2019, yet aga